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Abstract
Background: The feasibility of randomized trials often depends on successful patient recruitment.
Although numerous recruitment barriers have been identified it is unclear which of them
complicate recruitment most. Also, most surveys have focused on the patients' perspective of
recruitment barriers whereas the perspective of recruiting physicians has received less attention.
Therefore, our aim was to conduct a postal survey among recruiting physicians of a multi-center
trial to weigh barriers according to their impact on recruitment.
Methods: We identified any potential recruitment barriers from the literature and from our own
experience with a multi-center trial of respiratory rehabilitation in patients with chronic
obstructive pulmonary disease. We developed and pilot-tested a self-administered questionnaire
where recruiting physicians were asked to express their agreement with statements about
recruitment barriers on a Likert-type scale from 1 (full agreement with statement = very substantial
recruitment barrier) to 7 (no agreement with statement = no recruitment barrier).
Results: 38 of 55 recruiting physicians returned questionnaires (69% response rate), of which 35
could be analyzed (64% useable response rate). Recruiting physicians reported that "time
constraints" (median agreement of 3, interquartile range 2–5) had the most negative impact on
recruitment followed by "difficulties including identified eligible patients" (median agreement of 5,
IQR 3–6). Other barriers such as "trial design barriers", "lack of access to treatment", "individual
barriers of recruiting physicians" or "insufficient training of recruiting physicians" were perceived
to have little or no impact on patient recruitment.
Conclusion: Physicians perceived time constraints as the most relevant recruitment barrier in a
randomized trial. To overcome recruitment barriers interventions, that are affordable for both
industry- and investigator-driven trials, need to be developed and tested in randomized trials.
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Background
Patient recruitment is one of the greatest barriers in the
conduct of randomized controlled trials (RCT). Trials
from all medical specialties face problems in recruiting
patients. Barriers hampering recruitment can be due to
patient preferences, eligibility criteria, organizational
problems or other factors [1-15]. There is agreement that
every effort should be made during the planning stage and
during the trial to identify potential recruitment barriers
[16] and to choose adequate preventative measures to
minimize them [4,5,8,9,16-18]. However, measures
addressing potential recruitment barriers require substan-
tial financial and time resources and, often, it is not possi-
ble to take all of them. As a consequence of limited
resources it is essential to focus on the most important
barriers and to choose effective measures to minimize
them if available.
In recent years a number of studies aimed at identifying
barriers in patient recruitment as perceived by patients,
health care providers and investigators. Systematic
reviews summarizing these studies found that certain bar-
riers were identified consistently across studies including
system-related barriers (for example lack of study staff),
individual barriers (for example treatment preferences of
health care providers) and trial-design-related barriers (for
example restrictive eligibility criteria) [3,6,7,15,16]. These
studies are very informative to have an overview of any
type of recruitment barrier that might be present. They
had, however, two major limitations. First, their method-
ological quality was low [16] and second, the studies
offered no weighting of the importance of the identified
recruitment barriers. As discussed above, it is important to
prioritize those barriers that have the largest impact on
recruitment and where effective measures to counteract
them are available. To inform investigators, which barriers
should be prioritized when recruitment problems are
experienced or are to be expected, we conducted a postal
survey among physicians who recruit patients into a
multi-center RCT with substantial recruitment problems
in order to weigh the importance of a number of known
recruitment barriers.
Methods
Study design
We conducted a postal survey among recruiting physi-
cians of a respiratory rehabilitation trial enrolling patients
with Chronic Obstructive Pulmonary Disease (COPD). To
optimize the return rate of the questionnaires, we
informed the recruiting physicians in our quarterly elec-
tronic newsletter 2 weeks before mailing the question-
naires and reminded participants once electronically two
weeks after sending the questionnaire to them.
Description of the RCT
The trial is a multi-centre RCT on respiratory rehabilita-
tion in COPD patients in Switzerland (trial registration
ISRCTN84612310 on http://www.controlled-trials.com/
isrctn/). Patients are randomly assigned to either early
(within two weeks after completion of the exacerbation
treatment) or delayed respiratory rehabilitation after six
month in a stable pulmonary state. In some countries
such as Canada, the USA or France patients are usually
referred to respiratory rehabilitation only when patients
are in a stable state. Advantages of this approach are that
patients may adhere better to the training program. In
other countries including Switzerland, Germany or Aus-
tria patients are traditionally sent to early rehabilitation,
which may offer advantages in respect to effective patient
education ("window of opportunity" [19]) and continuity
of the post-exacerbation management. Both approaches
proved to be effective in meta-analyses of RCTs comparing
early and late rehabilitation with usual care (no rehabili-
tation) [20,21]. It is, however, unclear whether one
approach might be superior over the other. The primary
outcome of the trial is exacerbation requiring medical
treatment (event-based definition) and secondary out-
comes include health-related quality of life, mortality and
costs. Patients eligible for recruitment have COPD GOLD
stage II-IV and a history of repeated exacerbations. From
September 2006 to January 2009, only 37 patients were
randomized, which is still far from the target sample size
of 280. The RCT was approved by all regional ethic com-
mittees and patients provide written informed consent.
For the sub-study presented in this paper it was not neces-
sary to obtain additional ethical approval.
Participants
40 physicians from 24 hospitals and 15 physicians from
13 private practices are involved in the recruitment proc-
ess. They assess patients for eligibility (time requirement
of <5 minutes), inform patients about the study and ask
them for informed consent (20–30 minutes) and collect
the baseline data (20–30 minutes). Incentives to enroll
patients include group co-authorship and 200 Swiss
Francs per enrolled patient (around 120 Euro or 190 $).
We invited all recruiting physicians to participate in this
survey to avoid any selection bias [16]. Most of the physi-
cians work in the German-speaking part of Switzerland
(rural and urban areas) whereas few doctors work in the
French-speaking part of Switzerland. The recruiting physi-
cians hold different specializations, the most frequent
being General Internal Medicine and Respiratory Medi-
cine. We instructed each recruiting physician personally
about the recruitment process in one to three meetings
and provided the study material in printed or electronic
form as they preferred. The study coordinator (AS) and a
study nurse are available to support the recruiting physi-
cians in any aspect related to the recruitment process.BMC Medical Research Methodology 2009, 9:14 http://www.biomedcentral.com/1471-2288/9/14
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Questionnaire development and pilot testing
The questionnaire had two parts. In the first part we asked
the participants about age, work place setting, specializa-
tion, year of medical licensure and asked participants
about their personal recruitment success (number of eligi-
ble patients, number of eligible patients asked to partici-
pate and number of eligible patients who refused to
participate). In the second part we asked participants
about recruitment barriers. The questions about recruit-
ment barriers were developed as follows:
Item generation
The aim was to provide a comprehensive list of all poten-
tial barriers for recruitment in our RCT. We generated
potential questionnaire items based on the available liter-
ature, especially on the most recent systematic review of
Fayter et al. [16] on recruitment barriers and on the
"STEPS" study on strategies of trial enrollment by Camp-
bell et al. [8]. Furthermore we incorporated all concerns
and reasons of the involved physicians that were raised
during the recruitment process as well as the suggestions
proposed by the steering committee of the trial. We
merged items that were deemed to be too similar to be
assessed separately.
Item selection
After item generation, the members of the steering com-
mittee selected those items that applied to our RCT and
we included all of them in our questionnaire. These items
covered the following categories (Figure 1): "Time con-
straints" (3 items); "Difficulties including eligible
patients" (7 items); "Limited human resources" (7 items);
"Trial design barriers" (7 items); "Insufficient training of
recruiting physicians" (2 items); "Individual barriers of
recruiting physicians" (7 items); And "lack of access to
treatment" (2 items).
Development of questions and answer options
For each of the selected items a separate question was
developed and framed as a statement in German. For
example, one item read as follows (English translation):
"It is difficult for me to recruit a patient because I cannot
delegate the work to someone else when I do not have
time to do it myself". Participants then had to indicate
how strong they agreed with the particular statement. We
chose a Likert-type scale with 7 answer options ranging
from "I fully agree" (1) to "I completely disagree" (7) (Fig-
ure 2). Lower scores indicated a greater recruitment bar-
rier. The Likert-type scale offered respondents to express
their agreement quantitatively rather than providing only
a yes/no answer as it was done in earlier studies. Finally,
we offered respondents to list and rate any additional
statements describing recruitment barriers that were not
included in the questionnaire. Figure 2 shows the 35 ques-
tions, the questionnaire is available online as well (see
Additional file 1).
Pilot testing
After the development, we pilot tested the self-adminis-
tered questionnaire with 6 physicians who did not partic-
ipate in the survey to identify difficulties in understanding
or missing items.
Statistical analysis
For each item we calculated the median and the corre-
sponding interquartile range (IQR) and displayed the
results graphically using box plots. We combined the
medians of single items within categories by calculating
their median and IQR. All analyses were done with STATA
for Windows version 10 (Stata Corp; College Station, TX).
Results
38 out of 55 recruiting physicians returned the ano-
nymised questionnaire (return rate 69%). 3 physicians
did not answer any questions and returned a blank ques-
tionnaire, therefore, the useable response rate was 64%.
We included the remaining 35 physicians in the analysis,
whose questionnaires had few missing data (all items
with <3%). 16 physicians (46%) were based at a hospital,
6 (17%) were in private practice and 12 (34%) were both
at a hospital and in private practice (1 answer missing).
The median age of the participants was 47.5 years (IQR
42.5 – 54.3) and most of them were specialists of both
General Internal Medicine and Respiratory Medicine (23
physicians, 66%) whereas 6 physicians (17%) were spe-
cialists of Respiratory Medicine only. 22 physicians (63%)
had been participating in the trial since the beginning of
the trial and most of them had not yet recruited a patient
at the time of the survey (23 physicians, 66%). The
median number of eligible patients seen by recruiting
physicians in the 3 months previous to the survey was 3
(IQR 1–5). The median percentage of eligible patients
asked to participate, which also included informing the
patients and asking for informed consent, was 75% (IQR
35–100%). Recruiting physicians reported that most
patients identified to be eligible declined to participate
(median 100%, IQR 90–100%).
Overall result
Figure 2 shows the results for all 35 items as well as the
summary scores for each category. Overall, "time con-
straints" (items combined median 3 [IQR 2–5]), repre-
sented the greatest barrier to trial recruitment followed by
"Difficulties including eligible patients" (items combined
median 5 [IQR 3–6]). All other problems were not
regarded to represent substantial barriers to recruitment.BMC Medical Research Methodology 2009, 9:14 http://www.biomedcentral.com/1471-2288/9/14
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Question categories Figure 1
Question categories.
Question categories 
 
Category and covered topics        Number of items 
 
1) Time constraints 
Time and effort of recruitment          (3 items) 
 
2) Difficulties including eligible patients 
Objections  against  intervention      (4  items) 
 Too  strict  eligibility  criteria      (1  item) 
 Poor  reachability  of  patients      (1  item) 
 Competing  trials      (1  item) 
 
3) Limited human resources 
  Missing resources and support from trial coordinators    (3 items) 
  Missing organization and support within work setting    (4 items) 
 
4) Trial design barriers 
  Doubted scientific rationale of trial question      (3 items) 
Doubted relevance of the trial question        (2 items) 
 Complexity  of  the  trial       (2  items) 
 
5) Insufficient training of recruiting physicians 
 General  briefing  and  instruction      (1  item) 
  Understanding of randomization procedure      (1 item) 
 
6) Individual barriers of recruiting physicians 
  Ethical  concerns      (1  item) 
 Doubted  benefit  for  the  patient      (3  items) 
  Suspected negative effect on doctor-patient relationship    (2 items) 
 Missing  incentives       (1  item) 
 
7) Lack of access to treatment 
 Availability  of  rehabilitation  programs     (2  items) 
        T o t a l           3 5   i t e m s  BMC Medical Research Methodology 2009, 9:14 http://www.biomedcentral.com/1471-2288/9/14
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Results of all 35 questionnaire items Figure 2
Results of all 35 questionnaire items. Statements about potential recruitment barriers were assigned to 7 categories. Phy-
sicians were asked to express their agreement with these statements on a Likert-type scale from 1 to 7. Box plots with medi-
ans and interquartile ranges summarize the answers of the physicians. For each category a summary plot of the answers is 
presented. Because of limited space some of the questions are slightly shortened. For the original question, please see the 
appended questionnaire.BMC Medical Research Methodology 2009, 9:14 http://www.biomedcentral.com/1471-2288/9/14
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Detailed results
The three questions addressing "time constraints" were
answered homogenously (medians between 2.5 and 3).
The, on average, quite strong agreement with the three
statements shows that limited time resources represent a
substantial barrier to trial recruitment. However, IQR
were quite wide and indicate that there is some variability
in how physicians perceived time to be a critical factor for
patient recruitment.
"Inclusion of eligible patients" is difficult if patients do
not want to be randomized to late rehabilitation (median
3 [IQR 2-5]) or if trial participation is deemed to be too
complex by patients (median 3 [IQR 2-5]). Another bar-
rier represents the refusal of general practitioners, who see
many exacerbated COPD patients, to participate in the
recruitment process (median 3.5[IQR 2-6]).
"Limited human resources" in the organization of recruit-
ing physicians was, across all questions, not an important
barrier. However, recruiting physicians appear not to get
sufficient support from their team if they cannot do the
recruitment process themselves (median 3 [IQR 1-7]).
Also, local study personnel supporting recruitment would
be appreciated by some recruiting physicians (median 4
[2.5–7]). But variability in responses to these questions
was high again.
There was little heterogeneity across the questions about
"trial design barriers". The only item that recruiting physi-
cians reported to have some negative impact on recruit-
ment was "In my opinion, the trial arm "late
rehabilitation" does not correspond to actual best prac-
tice" (median 4.5 [IQR 3-6]). In general, recruiting physi-
cians felt to be trained adequately. Also, physicians did
not agree with the statements about potential own barri-
ers, which shows that ethical concerns, costs, incentives
and the relationship with patients or colleagues were not
significant barriers to recruitment. Finally, "lack of access
to treatment" (respiratory rehabilitation) was not consid-
ered by physicians to have a negative impact on recruit-
ment.
Discussion
Main findings
This survey suggests that time constraints and problems of
enrolling eligible patients represent the greatest barrier for
recruiting physicians of a multi-center RCT. Other barriers
including organizational problems, trial design-related
barriers, individual barriers and insufficient recruitment
training appear to have little or no impact on recruitment.
Strengths and weaknesses
Our survey had several strengths and limitations. First,
this is to our knowledge the first survey on recruitment
barriers that not only identifies recruitment barriers but
also provides a weighting in respect to their actual impact
on recruitment. Second, we tried to design and conduct a
survey of high methodological quality following the rec-
ommendations of Fayter et al. [16] who identified a
number of limitations in earlier surveys. For example, we
provided reporting of the survey design, methods of data
collection and analysis, we avoided selection bias by invit-
ing all recruiting doctors to participate in the survey, we
asked participants about any reasons for failure of recruit-
ment instead of asking only specific aspects of patient
recruitment, we provided respondents with the opportu-
nity to make additional comments, and we asked physi-
cians directly about recruitment barriers instead of asking
for reasons why patients refused to participate.
A limitation is that we only focused on recruitment barri-
ers from the physicians' perspective. We did not include
the patients' perspective because we did not have any
direct contact to patients before recruitment. We avoided
asking physicians about recruitment barriers from the
patients' perspective since this is likely to bias the results
[15]. Also, using fully structured anonymised question-
naires (this is standardized questions as well as standard-
ized answer options) offered no possibility to explore
individual recruitment barriers in more depth. Unstruc-
tured interviews would have provided more insights into
individual recruitment barriers. However, this would have
come at the price of not allowing for quantitative analyses
of the size of recruitment barriers as we did in the present
study. Another limitation is that the response rate was
64%. We cannot rule out the possibility of selection bias
with may have resulted in responses that are different
from those who did not participate in the survey. Finally,
although most of the questions addressed recruitment
problems encountered in many trials, some of the ques-
tions included in the questionnaire were specific for our
trial setting. This may impact the generalisability of some
of our findings. On the other hand, recruiting physicians
may provide better informed answers if the questions
address problems that are directly applicable to their situ-
ation. Overall, we do not think that our findings apply to
our trial setting only. Most physicians have substantial
time constraints in their daily practice and study duties are
likely to be of lower priority than clinical duties for most
physicians.
Recruitment barriers
Previous studies on recruitment problems in RCTs were
conducted mainly in oncology and to a smaller extent in
cardiovascular health and other disciplines. Also, most
studies focused on recruitment problems from the
patients' perspective whereas the physicians' perspective
has been considered less frequently. How do the results
from our survey compare to the results of previous stud-BMC Medical Research Methodology 2009, 9:14 http://www.biomedcentral.com/1471-2288/9/14
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ies? Surveys from the physicians' perspective in other clin-
ical settings (mainly oncology) also identified time
constraints, including time required to obtain informed
consent [16,3] and difficulties including eligible patients
[16] as a major barrier for patient recruitment. Also simi-
lar to our results, lack of incentives [3], trial design barriers
[16,3], limited human resources and insufficient training
of recruiting physicians [3] were only reported by a few
studies to represent major barriers.
The identification of the most important recruitment bar-
riers in the planning of a RCT is undoubtedly an impor-
tant prerequisite to assess the feasibility of a trial [16].
Still, it is important to note that a successful recruitment
also depends much on the motivation of recruiting physi-
cians for the study and how they communicate the study
to their patients [22]. We did not ask physicians in detail
about their motivation to participate and their under-
standing of the trial design because we did not think that
a postal survey would yield valid insights in regard to
these aspects. Although there are some clues in literature
regarding the importance of these factors [23], there is a
need to further evaluate the impact of these more complex
factors on recruitment success.
Interventions to minimize recruitment barriers
We found that major barriers for trial recruitment were
time constraints and the fact that eligible patients could
not be included in the trial for several reasons. Other fac-
tors appear to have almost no impact on recruitment, at
least from the physicians' perspective. These findings have
important implications for deciding about measures to
minimize recruitment barriers.
What is the evidence for the effectiveness of interventions
aimed at minimizing recruitment barriers from the physi-
cians' perspective? A systematic review [23] focused on
interventions to overcome barriers for clinicians to partic-
ipate in trials. No randomized trials were identified but
only observational studies that did not support any of the
interventions. Campbell et al. conducted an analysis of
114 trials and analyzed potentially influential factors on
trial recruitment[8]. However, they did not explicitly eval-
uate interventions to improve trial recruitment. Further
systematic reviews [4,17,18] focused primarily on inter-
ventions to overcome barriers to patient participation.
Thus it appears that most research on recruitment barriers
and on interventions to address these barriers have
focused on the patients' perspective.
To our knowledge, there are no randomized trials evaluat-
ing the effectiveness of interventions to minimize recruit-
ment barriers from the physicians' perspective. This is
surprising as many trials, especially multi-centre trials,
experience recruitment problems with physicians rather
than with patients [23]. Based on our results, the most
promising approach may be to address time constraints of
recruiting physicians. Obviously, providing sufficient
study personnel might be the most effective intervention.
But this might only be an option for industry-sponsored
trials with sufficient funding. For investigator-driven trials
alternatives are needed. A possible intervention is, for
example, to provide a study nurse in a certain catchment
area who regularly contacts participating physicians by
emails or phone calls and assists with time consuming
recruitment activities. Also offering co-authorship or
moderate financial incentives to recruiting physicians
may be effective strategies to motivate them to spend
more time with research activities. Neither our trial nor
previous studies provide valid estimates about the effects
of these measures to minimize recruitment barriers. The
most adequate way to test their impact on recruitment
remains a randomized trial that could be incorporated
into a randomized treatment trial.
Conclusion
From the recruiting physicians' perspective time con-
straints and difficulties including patients identified to be
eligible appear to have the largest impact on recruitment
in randomized trials. Effective but also affordable meas-
ures to minimize these important recruitment barriers
should be developed and evaluated.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors conceived the study idea; MP and AS designed
the study; AS collected the data; MP and AS analysed the
data and drafted the manuscript; All authors revised the
manuscript and approved the final version of the submit-
ted publication.
Additional material
Acknowledgements
This study was funded with unrestricted grants from: The Swiss Lung 
League, the Zurich Lung League, the Solothurn Lung League, the Valais Lung 
League, the Vaud Lung League, the Aargau Lung League, the Graubünden 
Lung League, the Thurgau Lung League, the Schaffhausen Lung League, the 
Luzern Lung League, the Nidwalden Lung League, the clinic Barmelweid, the 
Zurich Rehab Hospitals, Quadrimed and Astra Zeneca. M.A. Puhan's work 
was supported by the Swiss National Science Foundation (grant # 3233B0-
Additional file 1
Survey questionnaire. SOPRE study, Barriers to involvement in the study
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2288-9-14-S1.pdf]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Research Methodology 2009, 9:14 http://www.biomedcentral.com/1471-2288/9/14
Page 8 of 8
(page number not for citation purposes)
115216). These funding sources did not have any influence on the design, 
conduct, analysis and reporting of the study.
References
1. Ellis PM: Attitudes towards and participation in randomised
clinical trials in oncology: a review of the literature.  Ann Oncol
2000, 11(8):939-945.
2. Cox K, McGarry J: Why patients don't take part in cancer clin-
ical trials: an overview of the literature.  European journal of can-
cer care 2003, 12(2):114-122.
3. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Bar-
riers to participation in randomised controlled trials: a sys-
tematic review.  Journal of clinical epidemiology 1999,
52(12):1143-1156.
4. Mapstone JED, Roberts IG: Strategies to improve recruitment
to research studies.  Cochrane Database of Systematic Reviews
2004:MR000013.
5. Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL:
Recruitment for controlled clinical trials: literature sum-
mary and annotated bibliography.  Controlled clinical trials 1997,
18(4):328-352.
6. Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, Ellis P, Wright
JR:  Barriers to participation in clinical trials of cancer: a
meta-analysis and systematic review of patient-reported fac-
tors.  The Lancet Oncology 2006, 7(2):141-148.
7. Tournoux C, Katsahian S, Chevret S, Levy V: Factors influencing
inclusion of patients with malignancies in clinical trials.  Can-
cer 2006, 106(2):258-270.
8. Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM,
Knight R, Entwistle V, Garcia J, Roberts I, Grant A: Recruitment to
randomised trials: strategies for trial enrollment and partic-
ipation study. The STEPS study.  Health technology assessment
(Winchester, England) 2007, 11(48):iii. ix-105
9. Prescott RJ, Counsell CE, Gillespie WJ, Grant AM, Russell IT, Kiauka
S, Colthart IR, Ross S, Shepherd SM, Russell D: Factors that limit
the quality, number and progress of randomised controlled
trials.  Health technology assessment (Winchester, England) 1999,
3(20):1-143.
10. Langley C, Gray S, Selley S, Bowie C, Price C: Clinicians' attitudes
to recruitment to randomised trials in cancer care: a quali-
tative study.  Journal of health services research & policy 2000,
5(3):164-169.
11. Jones JM, Nyhof-Young J, Moric J, Friedman A, Wells W, Catton P:
Identifying motivations and barriers to patient participation
in clinical trials.  J Cancer Educ 2006, 21(4):237-242.
12. Grunfeld E, Zitzelsberger L, Coristine M, Aspelund F: Barriers and
facilitators to enrollment in cancer clinical trials: qualitative
study of the perspectives of clinical research associates.  Can-
cer 2002, 95(7):1577-1583.
13. Creel AH, Losina E, Mandl LA, Marx RJ, Mahomed NN, Martin SD,
Martin TL, Millett PJ, Fossel AH, Katz JN: An assessment of will-
ingness to participate in a randomized trial of arthroscopic
knee surgery in patients with osteoarthritis.  Contemporary clin-
ical trials 2005, 26(2):169-178.
14. Gaul C, Schmidt T, Helm J, Hoyer H, Haerting J: [Motivation and
barriers to participation in clinical trials].  Med Klin (Munich)
2006, 101(11):873-879.
15. Abraham NS, Young JM, Solomon MJ: A systematic review of rea-
sons for nonentry of eligible patients into surgical rand-
omized controlled trials.  Surgery 2006, 139(4):469-483.
16. Fayter D, McDaid C, Eastwood A: A systematic review highlights
threats to validity in studies of barriers to cancer trial partic-
ipation.  Journal of clinical epidemiology 2007, 60(10):990-1001.
17. Mc Daid C, Hodges Z, Fayter D, Stirk L, Eastwood A: Increasing
participation of cancer patients in randomised controlled tri-
als: a systematic review.  Trials 2006, 7:16.
18. Watson JM, Torgerson DJ: Increasing recruitment to ran-
domised trials: a review of randomised controlled trials.  BMC
medical research methodology 2006, 6:34.
19. Puhan MA: Respiratory rehabilitation after acute exacerba-
tions of chronic obstructive pulmonary disease.  International
Journal of Respiratory Care 2007, 2:90-93.
20. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS: Meta-analysis of
respiratory rehabilitation in chronic obstructive pulmonary
disease. A Cochrane systematic review.  Europa medicophysica
2007, 43(4):475-485.
21. Puhan MA, Scharplatz M, Troosters T, Steurer J: Respiratory reha-
bilitation after acute exacerbation of COPD may reduce risk
for readmission and mortality – a systematic review.  Respira-
tory research 2005, 6:54.
22. Fallowfield L, Ratcliffe D, Souhami R: Clinicians' attitudes to clin-
ical trials of cancer therapy.  Eur J Cancer 1997,
33(13):2221-2229.
23. Rendell JM, Merritt RD, Geddes JR: Incentives and disincentives
to participation by clinicians in randomised controlled trials.
Cochrane database of systematic reviews (Online) 2007:MR000021.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2288/9/14/prepub